Clinical Trials
5 trialsNCT01783522 2019-10-22
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT02215083 2017-07-12
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Phase 1 Withdrawn
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed
NCT02024191 2013-12-31
GELUPO
Ankara Education and Research Hospital
Phase 3 Unknown